Fidelity Investments
CAI

Fidelity Investments’s Caris Life Sciences CAI Stock Holding History

Fidelity Investments’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551M Buy
30,923,878
+138,293
+0.4% +$2.48M 0.02% 516
2026
Q1 		$550M Buy
30,785,585
+16,567,817
+117% +$362M 0.03% 474
2025
Q4 		$384M Buy
14,217,768
+4,584,333
+48% +$129M 0.02% 605
2025
Q3 		$291M Buy
9,633,435
+1,001,890
+12% +$31.9M 0.02% 700
2025
Q2 		$231M Buy
+8,631,545
New +$233M 0.01% 768

Other funds holding CAI

JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's CAI Position: Q2 2026 in Review

Fidelity Investments increased its Caris Life Sciences (CAI) stake by 0.45% in Q2 2026, buying an estimated $2.48M and bringing the position to 30,923,878 shares worth $551M. The position accounts for 0.02% of the portfolio, ranked #516.

Fidelity Investments first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Fidelity Investments held 30,923,878 shares of Caris Life Sciences worth $551M as of Q2 2026.
  • Fidelity Investments bought 138,293 Caris Life Sciences shares in Q2 2026, an estimated $2.48M.
  • Caris Life Sciences made up 0.02% of Fidelity Investments's portfolio in Q2 2026, its #516 holding.
  • Fidelity Investments first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.